- December 13, 2025
-
-
Loading
Loading
A publicly traded Sarasota biotechnology company has announced a public offering of up to $20 million of preferred stock.
Oragenics, which trades on the New York Stock Exchange under the ticker OGEN, is offering 800,000 shares of its stock at $25 per share, according to a statement.
The company says it plans to use the net proceeds from the offering, along with its existing cash, for several purposes:
